Replimune (REPL) Rent Expense (2021 - 2022)

Replimune (REPL) reported Rent Expense of $1.4 million for Q3 2022, little changed on a YoY basis from $1.4 million in Q3 2021, and down 0.63% sequentially from $1.4 million in Q2 2022.

Replimune (REPL) Rent Expense (2021 - 2022) Analysis & Trends

Replimune (REPL) has 2 years of Rent Expense data on file, last reported at $1.4 million in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Rental Exp. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Replimune 970.73 Mn 970.73 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2022 1.41 Mn
Sep 30, 2022 1.41 Mn
Jun 30, 2022 1.42 Mn
Jun 30, 2022 1.42 Mn
Sep 30, 2021 1.41 Mn
Sep 30, 2021 1.41 Mn
Jun 30, 2021 1.41 Mn
Jun 30, 2021 1.41 Mn